129 related articles for article (PubMed ID: 23566269)
21. SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.
Zhou G; Ting PC; Aslanian R; Cao J; Kim DW; Kuang R; Lee JF; Schwerdt J; Wu H; Herr RJ; Zych AJ; Yang J; Lam S; Wainhaus S; Black TA; McNicholas PM; Xu Y; Walker SS
Bioorg Med Chem Lett; 2011 May; 21(10):2890-3. PubMed ID: 21489787
[TBL] [Abstract][Full Text] [Related]
22. Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules.
Hopkins SC; Heffernan ML; Saraswat LD; Bowen CA; Melnick L; Hardy LW; Orsini MA; Allen MS; Koch P; Spear KL; Foglesong RJ; Soukri M; Chytil M; Fang QK; Jones SW; Varney MA; Panatier A; Oliet SH; Pollegioni L; Piubelli L; Molla G; Nardini M; Large TH
J Med Chem; 2013 May; 56(9):3710-24. PubMed ID: 23631755
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.
Howley E; Bestwick M; Fradley R; Harrison H; Leveridge M; Okada K; Fieldhouse C; Farnaby W; Canning H; Sykes AP; Merchant K; Hazel K; Kerr C; Kinsella N; Walsh L; Livermore DG; Hoffman I; Ellery J; Mitchell P; Patel T; Carlton M; Barnes M; Miller DJ
Neurochem Res; 2017 Nov; 42(11):3279-3288. PubMed ID: 28780732
[TBL] [Abstract][Full Text] [Related]
24. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine.
Hashimoto K; Fujita Y; Horio M; Kunitachi S; Iyo M; Ferraris D; Tsukamoto T
Biol Psychiatry; 2009 Jun; 65(12):1103-6. PubMed ID: 19217074
[TBL] [Abstract][Full Text] [Related]
25. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Sparey T; Abeywickrema P; Almond S; Brandon N; Byrne N; Campbell A; Hutson PH; Jacobson M; Jones B; Munshi S; Pascarella D; Pike A; Prasad GS; Sachs N; Sakatis M; Sardana V; Venkatraman S; Young MB
Bioorg Med Chem Lett; 2008 Jun; 18(11):3386-91. PubMed ID: 18455394
[TBL] [Abstract][Full Text] [Related]
26. Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity.
Park HK; Shishido Y; Ichise-Shishido S; Kawazoe T; Ono K; Iwana S; Tomita Y; Yorita K; Sakai T; Fukui K
J Biochem; 2006 Feb; 139(2):295-304. PubMed ID: 16452318
[TBL] [Abstract][Full Text] [Related]
27. Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.
Szilágyi B; Skok Ž; Rácz A; Frlan R; Ferenczy GG; Ilaš J; Keserű GM
Bioorg Med Chem Lett; 2018 Jun; 28(10):1693-1698. PubMed ID: 29699925
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.
Katane M; Osaka N; Matsuda S; Maeda K; Kawata T; Saitoh Y; Sekine M; Furuchi T; Doi I; Hirono S; Homma H
J Med Chem; 2013 Mar; 56(5):1894-907. PubMed ID: 23391306
[TBL] [Abstract][Full Text] [Related]
29. Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease.
Sagong HY; Bauman JD; Patel D; Das K; Arnold E; LaVoie EJ
J Med Chem; 2014 Oct; 57(19):8086-98. PubMed ID: 25225968
[TBL] [Abstract][Full Text] [Related]
30. A novel chiral ligand exchange capillary electrophoresis system with amino acid ionic liquid as ligand and its application in screening D-amino-acid oxidase inhibitors.
Mu X; Qi L; Shen Y; Zhang H; Qiao J; Ma H
Analyst; 2012 Sep; 137(18):4235-40. PubMed ID: 22858807
[TBL] [Abstract][Full Text] [Related]
31. Construction of a D-amino acid oxidase reactor based on magnetic nanoparticles modified by a reactive polymer and its application in screening enzyme inhibitors.
Mu X; Qiao J; Qi L; Liu Y; Ma H
ACS Appl Mater Interfaces; 2014 Aug; 6(15):12979-87. PubMed ID: 24980686
[TBL] [Abstract][Full Text] [Related]
32. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase.
Brandish PE; Chiu CS; Schneeweis J; Brandon NJ; Leech CL; Kornienko O; Scolnick EM; Strulovici B; Zheng W
J Biomol Screen; 2006 Aug; 11(5):481-7. PubMed ID: 16760370
[TBL] [Abstract][Full Text] [Related]
33. Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitors.
Toma L; Giovannoni MP; Vergelli C; Dal Piaz V; Kwon BM; Kim YK; Gelain A; Barlocco D
Arch Pharm (Weinheim); 2002; 335(11-12):563-6. PubMed ID: 12596221
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.
Kato Y; Hin N; Maita N; Thomas AG; Kurosawa S; Rojas C; Yorita K; Slusher BS; Fukui K; Tsukamoto T
Eur J Med Chem; 2018 Nov; 159():23-34. PubMed ID: 30265959
[TBL] [Abstract][Full Text] [Related]
35. Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent d-amino acid oxidase inhibitor.
Xie D; Lu J; Xie J; Cui J; Li TF; Wang YC; Chen Y; Gong N; Li XY; Fu L; Wang YX
Eur J Med Chem; 2016 Jul; 117():19-32. PubMed ID: 27089209
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase.
Tamayo N; Liao L; Goldberg M; Powers D; Tudor YY; Yu V; Wong LM; Henkle B; Middleton S; Syed R; Harvey T; Jang G; Hungate R; Dominguez C
Bioorg Med Chem Lett; 2005 May; 15(9):2409-13. PubMed ID: 15837335
[TBL] [Abstract][Full Text] [Related]
37. Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitors.
Lange JH; Venhorst J; van Dongen MJ; Frankena J; Bassissi F; de Bruin NM; den Besten C; de Beer SB; Oostenbrink C; Markova N; Kruse CG
Eur J Med Chem; 2011 Oct; 46(10):4808-19. PubMed ID: 21880399
[TBL] [Abstract][Full Text] [Related]
38. A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.
Gong N; Gao ZY; Wang YC; Li XY; Huang JL; Hashimoto K; Wang YX
J Pharmacol Exp Ther; 2011 Jan; 336(1):282-93. PubMed ID: 20952482
[TBL] [Abstract][Full Text] [Related]
39. Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 2: improvement of potency in vitro and in vivo.
Shimizu H; Yasumatsu I; Hamada T; Yoneda Y; Yamasaki T; Tanaka S; Toki T; Yokoyama M; Morishita K; Iimura S
Bioorg Med Chem Lett; 2011 Feb; 21(3):904-8. PubMed ID: 21232950
[TBL] [Abstract][Full Text] [Related]
40. Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.
Byth KF; Cooper N; Culshaw JD; Heaton DW; Oakes SE; Minshull CA; Norman RA; Pauptit RA; Tucker JA; Breed J; Pannifer A; Rowsell S; Stanway JJ; Valentine AL; Thomas AP
Bioorg Med Chem Lett; 2004 May; 14(9):2249-52. PubMed ID: 15081018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
